Clinical Application of Image-Guided Liver Surgery

Status Terminated

Clinical Trial Summary

Image-guided surgery is a new technology, which is used to create 3-D pictures that generate a map of the liver. This map will allow surgeons to know the exact anatomical location of their instruments, including instances when direct visualization is not possible. This study is designed to determine the safety and feasibility of using image-guided techniques for treatment of liver tumors. The overall goal of this study is to use image-guided surgery for the improvement of the surgeon's ability to remove liver tumors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00878215
Study type	Interventional
Source	Washington University School of Medicine
Contact
Status	Terminated
Phase	Phase 2
Start date	October 24, 2002
Completion date	May 25, 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03971201` - A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion	Phase 2
Recruiting	`NCT04484636` - PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)	N/A
Recruiting	`NCT05489250` - The PLATON Network
Completed	`NCT01967823` - T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer	Phase 2
Completed	`NCT04212286` - Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC	N/A
Recruiting	`NCT05992220` - Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion	Phase 2
Completed	`NCT02073435` - A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Active, not recruiting	`NCT01522937` - A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer	Phase 2
Terminated	`NCT05061537` - Study of PF-07263689 in Participants With Selected Advanced Solid Tumors	Phase 1
Active, not recruiting	`NCT04166240` - Measuring and Improving the Safety of Test Result Follow-Up	N/A
Withdrawn	`NCT02288507` - Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer	Phase 1
Terminated	`NCT03026803` - A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer	Phase 2
Active, not recruiting	`NCT04682847` - Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Active, not recruiting	`NCT05100082` - Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma
Active, not recruiting	`NCT03195699` - Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers	Phase 1
Completed	`NCT02616692` - HCC Patient Preferences in Japan	N/A
Active, not recruiting	`NCT03132792` - AFPᶜ³³²T in Advanced HCC	Phase 1
Recruiting	`NCT01849588` - Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C	Phase 4
Suspended	`NCT00909558` - Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer	Phase 1
Completed	`NCT00997022` - Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients	Phase 1